International Reagent Resources



Publications
The following is a list of published abstracts and papers where the work was either facilitated, or directly supported, by the International Reagent Resource Program.

Influenza
Adel, Amany, Abdelsatar Arafa, Hussein A. Hussein, and Ahmed A. El-Sanousi.. "Molecular and antigenic traits on hemagglutinin gene of avian influenza H9N2 viruses: Evidence of a new escape mutant in Egypt adapted in quails." Research in Veterinary Science 112 (2017): 132-140. https://doi.org/10.1016/j.rvsc.2017.02.003

Anderson, Caitlin E., Carly A. Holstein, Eva-Maria Strauch, Steven Bennett, Aaron Chevalier, Jorgen W. Nelson, Elain Fu, David Baker, and Paul Yager."A Rapid Diagnostic Assay for Intact Influenza Virus Using a High Affinity Hemagglutinin Binding Protein." Analytical Chemistry (2017). DOI: 10.1021/acs.analchem.7b00769

Andrey, Komissarov, Artem, F., Anna, K., & Mikhail, G "Development of a real time RT-PCR assay for the rapid detection of influenza A (H2) viruses." Molecular and Cellular Probes (2017). https://doi.org/10.1016/j.mcp.2017.06.005

Babady, E, Laplante J, Tang Y and St George, K. "Detection of a transient R292K mutation in Influenza A/H3N2 viruses shed for several weeks by an immunocompromised patient." Journal of clinical microbiology 53.4 (2015): 1415-1418. doi:10.1128/JCM.02845-14.

Bangaru, S., Nieusma, T., Kose, N., Thornburg, N. J., Finn, J. A., Kaplan, B. S., ... & Cisneros, A. (2016). Recognition of influenza H3N2 variant virus by human neutralizing antibodies. JCI Insight, 1(10).

Bednarska, K., Hallmann-Szelińska, E., Kondratiuk, K., & Brydak, L. B. (2016). Antigenic Drift of A/H3N2/Virus and Circulation of Influenza-Like Viruses During the 2014/2015 Influenza Season in Poland.

Blanchfield, K., Kamal, R. P., Tzeng, W. P., Music, N., Wilson, J. R., Stevens, J., ... & York, I. A. (2014). Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins. Influenza and other respiratory viruses, 8(6), 628-635.doi: 10.1111/irv.12285

Bose, M. E., McCaul, K. C., Mei, H., Sasman, A., He, J., Kramp, W., ... & Henrickson, K. J. (2016). Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays. PloS one, 11(11), e0166800. http://dx.doi.org/10.1371/journal.pone.0166800

Broberg, E., Pereyaslov, D., Struelens, M., Palm, D., Meijer, A., Ellis, J., ... & Daniels, R. (2013). Laboratory preparedness in EU/EEA countries for detection of novel avian influenza A (H7N9) virus, May 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles= European communicable disease bulletin, 19(4). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20682

Burnell FJ, Holmes MA, Roiko AH, Lowe JB, Heil GL, White SK, Gray GC (2014) Little evidence of human infection with equine influenza during the 2007 epizootic, Queensland, Australia. J Clin Virol 59:100–103. doi: 10.1016/j.jcv.2013.11.011.

Byrn, R., Jones S., Bennett H.,Bral, C., Clark M., Jacobs M., Kwong A., et al. "Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit." Antimicrobial agents and chemotherapy 59.3 (2015): 1569-1582. doi: 10.1128/AAC.04623-14

Carter DM, Lu H-R, Bloom CE, Crevar CJ, Cherry JL, et al. (2012) Complex Patterns of Human Antisera Reactivity to Novel 2009 H1N1 and Historical H1N1 Influenza Strains. PLoS ONE 7(7): e39435. doi:10.1371/journal.pone.0039435

Carter, D. M., Darby, C. A., LeFoley, B. C., Crevar, C. J., Alefantis, T., Oomen, R., ... & Parrington, M. (2016). Design and Characterization of a COBRA HA vaccine for H1N1 influenza viruses. Journal of virology, JVI-03152. doi:10.1128/JVI.03152-15

Chambers BS, Li Y, Hodinka RL,Hensley SE (2014) Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. J Virol 88:10986–10989. doi:10.1128/JVI.01077-14

Cieślak, K., Kowalczyk, D., Szymański, K., & Brydak, L. B. (2017). The Sentinel System as the Main Influenza Surveillance Tool. Doi: 10.1007/5584_2016_205

Coman A, Maftei DN, Krueger WS, Heil GL, Chereches RM, et al. (2014) A Prospective Study of Romanian Agriculture Workers for Zoonotic Influenza Infections. PLoS ONE 9(5): e98248. doi:10.1371/journal.pone.0098248

Dauner, A., Agrawal, P., Salvatico, J., Tapia, T., Dhir, V., Shaik, S. F. & Byers, A. M. (2017). The in vitro MIMIC® platform reflects age-associated changes in immunological responses after influenza vaccination. Vaccine. https://doi.org/10.1016/j.vaccine.2017.03.099

Fontana JM, Christos PJ, Michelini Z, Negri D, Cara A, et al. (2014) Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice. PLoS ONE 9(5): e97270. doi:10.1371/journal.pone.0097270

Gallagher, John R., Udana Torian, Dustin M. McCraw, and Audray K. Harris. "Structural studies of influenza virus RNPs by electron microscopy indicate molecular contortions within NP supra-structures." Journal of structural biology 197.3 (2017): 294-307.

Hallmann-Szelińska, E., Bednarska, K., Korczyńska, M., Paradowska-Stankiewicz, I., & Brydak, L. B. (2016). Virological Characteristics of the 2014/2015 Influenza Season Based on Molecular Analysis of Biological Material Derived from I-MOVE Study.

Harvey, J. J., Chester, S., Burke, S. A., Ansbro, M., Aden, T., Gose, R., ... & Hall, J. (2015). Comparative Analytical Evaluation of the Respiratory TaqMan Array Card with Real-Time PCR and Commercial Multi-Pathogen Assays. Journal of virological methods. doi:10.1016/j.jviromet.2015.11.020

Holstein, C., Bennett, S., Strauch, E. M., Chevalier, A., Fu, E., Baker, D., & Yager, P. (2014, October). Development of a paper-based diagnostic for influenza detection. In Healthcare Innovation Conference (HIC), 2014 IEEE (pp. 296-299). IEEE. doi: 10.1109/HIC.2014.7038933

Holthausen, David J., Song Hee Lee, Vineeth TV Kumar, Nicole M. Bouvier, Florian Krammer, Ali H. Ellebedy, Jens Wrammert et al. "An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses." Immunity 46.4 (2017): 587-595.

Horwood, P.F., Horm, S.V., Suttie, A., Thet, S., Phalla, Y., Rith, S., Sorn, S., Holl, D., Tum, S., Ly, S. and Karlsson, E.A. (2018). Co-circulation of Influenza A H5, H7, and H9 Viruses and Co-infected Poultry in Live Bird Markets, Cambodia.

Hu, Y., Wang, Y., Li, F., Ma, C., & Wang, J. (2017). Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses. European Journal of Medicinal Chemistry, 135, 70-76. https://doi.org/10.1016/j.ejmech.2017.04.038

Huang SSH, Banner D, Fang Y, Ng DCK, Kanagasabai T, et al. (2011) Comparative Analyses of Pandemic H1N1 and Seasonal H1N1, H3N2, and Influenza B Infections Depict Distinct Clinical Pictures in Ferrets. PLoS ONE 6(11): e27512. doi:10.1371/journal.pone.0027512

Jagadesh, A., Salam, A. A. A., Zadeh, V. R., & Arunkumar, G. (2016). Genetic analysis of neuraminidase gene of influenza A (H1N1) pdm09 virus circulating in Southwest India from 2009 to 2012. Journal of Medical Virology. doi/10.1002/jmv.24625

Jens Wrammert, Dimitrios Koutsonanos, Gui-Mei Li, Srilatha Edupuganti, Jianhua Sui, Michael Morrissey, Megan McCausland, Ioanna Skountzou, Mady Hornig, W. Ian Lipkin, Aneesh Mehta, Behzad Razavi, Carlos Del Rio, Nai-Ying Zheng, Jane-Hwei Lee, Min Huang, Zahida Ali, Kaval Kaur, Sarah Andrews, Rama Rao Amara, Youliang Wang, Suman Ranjan Das, Christopher David O'Donnell, Jon W. Yewdell, Kanta Subbarao, Wayne A. Marasco, Mark J. Mulligan, Richard Compans, Rafi Ahmed, Patrick C. Wilson. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med. 2011 January 17; 208(1): 181–193. doi: 10.1084/jem.20101352 Correction in: J Exp Med. 2011 February 14; 208(2): 411. PMCID: PMC3023136

Jernigan, D. B., Lindstrom, S. L., Johnson, J. R., Miller, J. D., Hoelscher, M., Humes, R., Shaw, M. W. (2011). Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clinical Infectious Diseases, 52(suppl 1), S36-S43. doi:10.1093/cid/ciq020.

Johnson, L. E., Muir-Paulik, S. A., Kennedy, P., Lindstrom, S., Balish, A., Aden, T., & Moen, A. C. (2015). Capacity building in national influenza laboratories–use of laboratory assessments to drive progress. BMC infectious diseases, 15(1), 1. DOI: 10.1186/s12879-015-1232-1

Julia Steitz, Peter G. Barlow, Jaber Hossain, Eun Kim, Kaori Okada, Tom Kenniston, Sheri Rea, Ruben O. Donis, Andrea Gambotto. A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice. PLoS One. 2010; 5(5): e10492. Published online 2010 May 5. doi: 10.1371/journal.pone.0010492 PMCID: PMC2864737

Keitel, W. A., Jackson, L. A., Edupuganti, S., Winokur, P. L., Mulligan, M. J., Thornburg, N. J., Segar, E. (2015). Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A/H3N2 Variant (H3N2v) Vaccine in Healthy Persons≥ 18 Years Old. Journal of Infectious Diseases, jiv056.doi: 10.1093/infdis/jiv056

Kelvin, A. A., Degousee, N., Banner, D., Stefanski, E., Leόn, A. J., Angoulvant, D., ... & Rubin, B. B. (2014). Lack of group X secreted phospholipase A 2 increases survival following pandemic H1N1 influenza infection. Virology, 454, 78-92.doi:10.1016/j.virol.2014.01.030

Khurelbaatar N, Krueger WS, Heil GL, Darmaa B, Ulziimaa D, et al. (2014) Little Evidence of Avian or Equine Influenza Virus Infection among a Cohort of Mongolian Adults with Animal Exposures, 2010–2011. PLoS ONE 9(1): e85616. doi:10.1371/journal.pone.0085616

Kossyvakis, A., Mentis, A. F., Tryfinopoulou, K., Pogka, V., Kalliaropoulos, A., Antalis, E., ... & Mentis, A. F. (2016). Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment. European Journal of Clinical Microbiology & Infectious Diseases, 1-11. doi:10.1007/s10096-016-2809-3

Kumar, A., Kim, J. H., Ranjan, P., Metcalfe, M. G., Cao, W., Mishina, M., ... & York, I. (2017). Influenza virus exploits tunneling nanotubes for cell-to-cell spread. Scientific Reports, 7. doi: 10.1038/srep40360

Laurie, K.L., Horman, W., Carolan, L.A., Chan, K.F., Layton, D., Bean, A., Vijaykrishna, D., Reading, P.C., McCaw, J.M. and Barr, I.G. (2018). Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages. The Journal of infectious diseases. https://doi.org/10.1093/infdis/jix509

Lewis, N. S., Anderson, T. K., Kitikoon, P., Skepner, E., Burke, D. F., & Vincent, A. L. (2014). Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in US swine.Journal of virology, 88(9), 4752-4763. doi:10.1128/JVI.03805-13

Li, Y, "The Impact Of Receptor Binding Avidity And Immune History On The Antigenic Determination Of Influenza A Viruses" (2013). Publicly Accessible Penn Dissertations. Paper 888.http://repository.upenn.edu/edissertations/888

Li, Z. N., Weber, K. M., Limmer, R. A., Horne, B. J., Stevens, J., Schwerzmann, J., ... & Jernigan, D. B. (2017). Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responses influenza HA subtype specific antibody . http://dx.doi.org/10.1016/j.jviromet.2017.01.008

Lin, S. C., Kappes, M. A., Chen, M. C., Lin, C. C., & Wang, T. T. (2017). Distinct susceptibility and applicability of MDCK derivatives for influenza virus research. PloS one, 12(2), e0172299. http://dx.doi.org/10.1371/journal.pone.0172299

Ma, C., Li, F., Musharrafieh, R., & Wang, J. (2016). Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance. Antiviral Research.

Matzinger S, T Carroll, J Dutra, Z Ma, C Miller. (2012) Myxovirus Resistance Gene A (MxA) Expression Suppresses Influenza A Virus Replication in Alpha Interferon-Treated Primate Cells. J. Virol.. 87:21150-1158. doi:10.1128/JVI.02271-12

McCarthy, K.R., Watanabe, A., Kuraoka, M., Do, K.T., McGee, C.E., Sempowski, G.D., Kepler, T.B., Schmidt, A.G., Kelsoe, G. and Harrison, S.C. (2018). Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires. Immunity, 48(1), 174-184.

Melidou, A., G. Gioula, M. Exindari, E. Ioannou, K. Gkolfinopoulou, T. Georgakopoulou, S. Tsiodras, and A. PapaΙnfluenza A (H3N2) genetic variants in vaccinated patients in northern Greece." Journal of Clinical Virology 94 (2017): 29-32. https://doi.org/10.1016/j.jcv.2017.07.003

Morrison, Brian, Roman, J. A., Luke, T. C., Nagabhushana, N., Raviprakash, K., Williams, M., & Sun, P. (2017). Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A (H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy. Journal of Virological Methods. https://doi.org/10.1016/j.jviromet.2017.06.007

Music N, Reber AJ, Lipatov AS, Kamal RP, Blanchfield K, et al. (2014) Influenza Vaccination Accelerates Recovery of Ferrets from Lymphopenia. PLoS ONE 9(6): e100926. doi:10.1371/journal.pone.0100926

Nicole A. Karras, Matthew Weeres, Wendy Sessions, Xiyan Xu, Todd DeFor, Jo-Anne H. Young, Heather Stefanski, Claudio Brunstein, Sarah Cooley, Jeffrey S. Miller, Bruce R. Blazar, John E. Wagner, Michael R. Verneris, A Randomized Trial of One versus Two Doses of Influenza Vaccine after Allogeneic Transplantation, Biology of Blood and Marrow Transplantation, Available online 29 August 2012, ISSN 1083-8791, 10.1016/j.bbmt.2012.08.015. (http://www.sciencedirect.com/science/article/pii/S1083879112003497)

Nogales, Aitor, et al. "Reverse Genetics of Influenza B Viruses." Reverse Genetics of RNA Viruses: Methods and Protocols (2017): 205-238.

Nunes, M. C., Cutland, C. L., Jones, S., Hugo, A., Madimabe, R., Simões, E. A., ... & Madhi, S. A. (2016). Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial. JAMA pediatrics. doi:10.1001/jamapediatrics.2016.0921

Okoye, J. O., Eze, D. C., Krueger, W. S., Heil, G. L., White, S. K., Merrill, H. R., & Gray, G. C. (2014). Evidence for subclinical H5N1 avian influenza infections among Nigerian poultry workers. Journal of medical virology, 86(12), 2070-2075. doi: 10.1002/jmv.23909

Paquette, S. G., Banner, D., Leόn, A. J., Xu, L., Ran, L., Huang, S. S., Kelvin, A. A. (2014). Pandemic H1N1 influenza A directly induces a robust and acute inflammatory gene signature in primary human bronchial epithelial cells downstream of membrane fusion. Virology, 448, 91-103.doi:10.1016/j.virol.2013.09.022

Paquette, Stéphane G. Banner, D., Huang, S. S., Almansa, R., Leon, A., Xu, L., ... & Kelvin, A. A. (2015). Influenza Transmission in the Mother-Infant Dyad Leads to Severe Disease, Mammary Gland Infection, and Pathogenesis by Regulating Host Responses. PLoS pathogens, 11(10). doi: 10.1371/journal.ppat.1005173

Pauly, Matt D., Megan Procario, and Adam S. Lauring. "The mutation rates and mutational bias of influenza A virus." bioRxiv (2017): 110197.

Pauly, Matthew D., Megan C. Procario, and Adam S. Lauring. "A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses." eLife 6 (2017).

Perez, Daniel R., et al. "Plasmid-Based Reverse Genetics of Influenza A Virus." Reverse Genetics of RNA Viruses: Methods and Protocols (2017): 251-273.

Pierce, Carrie L., Tracie L. Williams, Wanda I. Santana, Marnie Levine, Li-Mei Chen, Hans C. Cooper, Maria I. Solano et al. "Immunocapture isotope dilution mass spectrometry in response to a pandemic influenza threat." Vaccine 35.37 (2017): 5011-5018. https://doi.org/10.1016/j.vaccine.2017.07.049

Pollett, S., Nelson, M. I., Kasper, M., Tinoco, Y., Simons, M., Romero, C., ... & Bausch, D. G. (2015). Phylogeography of Influenza A (H3N2) Virus in Peru, 2010–2012. Emerging infectious diseases, 21(8), 1330. DOI: 10.3201/eid2108.150084

Reber, A. J., Kim, J. H., Coleman, L. A., Spencer, S. M., Chung, J. R., Chen, J., & Katz, J. M. (2016). Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity with Past and Future Strains. Journal of Infectious Diseases, jiw380.

Seleka, Mpho, Florette K. Treurnicht, Stefano Tempia, Orienka Hellferscee, Senzo Mtshali, Adam L. Cohen, Amelia Buys et al. "Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014." PloS one 12.5 (2017): e0177655.

Sequeira, Daniela P., Ricardo Correia, Manuel JT Carrondo, António Roldão, Ana P. Teixeira, and Paula M. Alves. "Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production."Vaccine(2017). https://doi.org/10.1016/j.vaccine.2017.02.043

Shore, D. A., Yang, H., Balish, A. L., Shepard, S. S., Carney, P. J., Chang, J. C., Stevens, J. (2013). Structural and antigenic variation among diverse clade 2 H5N1 viruses. PloS one, 8(9), e75209.doi: 10.1371/journal.pone.0075209

Simões, E. A., Weinberg, A., & Madhi, S. A. (2016). Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization Secondary Analysis of a Randomized Clinical Trial.

Steitz J, Barlow PG, Hossain J, Kim E, Okada K, et al. (2010) A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice. PLoS ONE 5(5): e10492. doi:10.1371/journal.pone.0010492

Strauch, Eva-Marie, Bernard, S. M., La, D., Bohn, A. J., Lee, P. S., Anderson, C. E., ... & Ravichandran, R. (2017). Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site. Nature Biotechnology. doi:10.1038/nbt.3907

Sun, Xiangjie, Jessica A. Belser, Joanna A. Pulit-Penaloza, Hannah M. Creager, Zhu Guo, Stacie N. Jefferson, Feng Liu et al. "Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3. 4.4 virus challenge in ferrets." Virology 508 (2017): 164-169.

Tielsch, J. M., Steinhoff, M., Katz, J., Englund, J. A., Kuypers, J., Khatry, S. K, LeClerq, S. C. (2015). Designs of two randomized, community-based trials to assess the impact of influenza immunization during pregnancy on respiratory illness among pregnant women and their infants and reproductive outcomes in rural Nepal. BMC pregnancy and childbirth, 15(1), 40 doi:10.1186/s12884-015-0470-y

Watson, J. M., Francis, J. N., Mesens, S., Faiman, G. A., Makin, J., Patriarca, P, Bunce, C. J. (2015). Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans. Virology journal,12(1), 13. doi: 10.1186/s12985-015-0240-5

White, J. A., Estrada, M., Flood, E. A., Mahmood, K., Dhere, R., & Chen, D. (2016). Development of a stable liquid formulation of live attenuated influenza vaccine. Vaccine.

White, K. M., Ayllon, J., Mena, I., Potenski, A., Krammer, F., & García-Sastre, A. (2018). Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation. Vaccine. https://doi.org/10.1016/j.vaccine.2018.01.050

Willis, E., Parkhouse, K., Krammer, F., & Hensley, S. E. (2016). Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States. Vaccine. http://dx.doi.org/10.1016/j.vaccine.2016.09.017

Wilson, J. R., Guo, Z., Reber, A., Kamal, R. P., Music, N., Gansebom, S., ... & Stevens, J. (2016). An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo. Antiviral Research. http://dx.doi.org/10.1016/j.antiviral.2016.10.001

Wong, Terianne M., James D. Allen, Anne-Gaelle Bebin-Blackwell, Donald M. Carter, Timothy Alefantis, Joshua DiNapoli, Harold Kleanthous, and Ted M. Ross. (2017). Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants. Journal of Virology, 91(24), e01581-17.

Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, McCausland M, Skountzou I, Hornig M, Lipkin WI, Mehta A, Razavi B, Del Rio C, Zheng NY, Lee JH, Huang M, Ali Z, Kaur K, Andrews S, Amara RR, Wang Y, Das SR, O’Donnell CD, Yewdell JW, Subbarao K, Marasco WA, Mulligan MJ, Compans R, Ahmed R, Wilson PC (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208:181–193. http://dx.doi.org/10.1084/jem.20101352.

Wu, Y., Cho, M., Shore, D., Song, M., Choi, J., Jiang, T, & Donis, R. O. (2015). A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus. Nature communications, 6. doi:10.1038/ncomms8708

Yager, P., Anderson, C., Baker, D., Lin, Y. R., & Holstein, C. (2017). "POROUS MEMBRANE-BINDING PEPTIDES." U.S. Patent No. 20,170,082,624. Washington, DC: U.S. Patent and Trademark Office.

Zhong, W., Gross, F. L., Holiday, C., Jefferson, S. N., Bai, Y., Liu, F., ... & Levine, M. Z. (2016). Vaccination with 2014–15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans. Viral immunology. doi:10.1089/vim.2016.0003

ATCC. All Rights Reserved. View full site
top